CSPC PHARMA (01093) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

CSPC PHARMA (01093.HK) canceled 57.58 million repurchased shares on December 10.
On December 10, Gelonghui reported that cspc pharma (01093.HK) announced the cancellation of a total of 57.58 million repurchased shares on December 10, 2024.
Gelonghui FinanceDec 10 03:45 ET
Announcement highlights | Longfor Group's sales exceeded 90 billion yuan this year; Mao Geping announced the lottery results, listed this morning.
In the first 11 months, longfor group achieved a total contract sales amount of 93 billion yuan, with contract sales of 8.5 billion yuan in November; cspc pharma's application for marketing approval for SYHX2011 to treat advanced breast cancer was accepted.
cls.cnDec 9 18:57 ET
Hong Kong Stock Announcement | The public offering of Maoge Ping has received a subscription rate of 919.18 times.
In November, q tech (01478) sold approximately 40.306 million mobile camera modules, an increase of 5.4% compared to the previous month.
Zhitong FinanceDec 9 10:05 ET
CSPC Pharmaceutical Unit Gets Chinese Drug Regulator's Marketing Approval for Breast Cancer Drug
MT NewswiresDec 9 06:38 ET
cspc pharma (01093.HK): The listing application for SYHX2011 for the treatment of advanced breast cancer has been accepted.
On December 9, in a public announcement, cspc pharma (01093.HK) stated that the listing application for SYHX2011, developed by its subsidiary cspc pharma (Europe) Co., Ltd., has been formally accepted by the National Medical Products Administration of china. Breast cancer is a common malignant tumor among women, and taxanes are the most effective cytotoxic chemotherapy drugs for advanced breast cancer. Whether treated alone or in combination, they have been proven to offer greater survival benefits compared to other types of chemotherapy drugs. This product is based on paclitaxel injection (albumin-bound) and is an innovative nanoformulation developed using patented technology, with.
Gelonghui FinanceDec 9 04:59 ET
Express News | CSPC Pharmaceutical - Acceptance of Application for Marketing Approval of Syhx2011 by Nmpa
ReutersDec 9 04:56 ET

Comments

CareRareFair

Oct 31 08:28

$CSPC PHARMA (01093.HK)$ my greatest mistake to buy heavily this stupid stock. 重仓石药集团这只瘟股是我最大的失误。公司管理层真是石头一堆

1

CareRareFair

Oct 13 20:44

$CSPC PHARMA (01093.HK)$ may go back to below 6 soon. a strange company, need to dump

Bull X Bear

Oct 3 02:14

What would you buy in your Hong Kong portfolio?

Banks: $ABC (01288.HK)$ $BANK OF CHINA (03988.HK)$
Securities & Brokerage: $HTSC (06886.HK)$ $CMSC (06099.HK)$
Gaming Software: $NTES-S (09999.HK)$ $XD INC (02400.HK)$ $NETDRAGON (00777.HK)$
Digital Solutions: $TENCENT (00700.HK)$ $TRAVELSKY TECH (00696.HK)$ $CHINASOFT INT'L (00354.HK)$
Online Retailer: $BABA-W (09988.HK)$ $MEITUAN-W (03690.HK)$ $JD-SW (09618.HK)$
Insurer: $PING AN (02318.HK)$ $AIA (01299.HK)$ $CHINA LIFE (02628.HK)$
Telecommunication: $CHINA MOBILE (00941.HK)$ $CHINA TELECOM (00728.HK)$
...

Officials say the real estate market is bottoming out. What’s your view on China's property market?

15

7

CareRareFair

Aug 22 01:59

$CSPC PHARMA (01093.HK)$ over sold. the management should seriously review its strategy. with huge expense input in R&D but the end results are so weak.

1

Moomoo AI

Jan 27 18:58

CSPC Pharmaceutical Group insiders' transactions over the last year indicate alignment with shareholders and optimism for the future. However, no insider trading occurred in the last quarter.

One CSPC Pharmaceutical Group Insider Raised Their Stake In The Previous Year

1

01093 CSPC PHARMA

Trade Overview

Capital Trend

News

Comments